Signor M, Fongione S
Istituto di Radioterapia Oncologica, Azienda Ospedaliera S. Maria della Misericordia, Udine.
Minerva Chir. 1997 Dec;52(12):1487-93.
Intraoperative radiotherapy consists in the irradiation of the affected area, exposed using anesthesiological and laparotomic procedures, following the removal of a neoplasia using palliative or macroscopically radical surgical. This increases local tumour control and augments the selectivity of treatment between healthy and neoplastic tissues, thus obtaining a marked improvement in survival or palliation. The authors analyse the data reported in international literature regarding the possible use of intraoperative radiotherapy in patients undergoing abdomino-pelvic oncological surgery. The aim of the study was to evaluate this method for use in selected and combined treatment in which surgery represents an obligatory step. Studies were carried out in a few highly specialised centres given that special technical, logistic and professional skills were required. The populations studied were often very small with a marked prevalence of feasibility studies compared to random studies. In spite of this intraoperative radiotherapy is undoubtedly indicated in locally advanced gastric, rectal and vesical neoplasia, it represents a valid palliative solution in pancreatic neoplasia and in pelvic recidivation, and an effective alternative solution to mutilating surgery in the initial stages of vesical cancer. Positive results are obtained in prostate and uterine cancer, but they are reported by non-conclusive studies. Toxicity is acceptable and non-limiting within a given range of doses and irradiated volume. The "repercussion" in terms of knowledge, experience, scientific integration between oncological surgeons and radiotherapists is basic, with a marked improved in the management of cancer treatment.
术中放疗包括在通过姑息性或肉眼根治性手术切除肿瘤后,对经麻醉和剖腹手术暴露的患区进行照射。这提高了局部肿瘤控制率,增强了健康组织与肿瘤组织之间治疗的选择性,从而显著提高了生存率或缓解效果。作者分析了国际文献中报道的关于在接受腹盆腔肿瘤手术的患者中可能使用术中放疗的数据。该研究的目的是评估这种方法在以手术为必要步骤的选择性联合治疗中的应用。鉴于需要特殊的技术、后勤和专业技能,研究在少数高度专业化的中心进行。所研究的人群往往非常少,与随机研究相比,可行性研究的比例明显更高。尽管如此,术中放疗无疑适用于局部晚期胃癌、直肠癌和膀胱癌,在胰腺癌和盆腔复发中是一种有效的姑息性解决方案,在膀胱癌早期是一种替代根治性手术的有效解决方案。在前列腺癌和子宫癌中取得了阳性结果,但这些结果来自非结论性研究。在给定的剂量范围和照射体积内,毒性是可接受的且无限制。肿瘤外科医生和放疗科医生在知识、经验和科学整合方面的“反响”至关重要,癌症治疗的管理有了显著改善。